ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000234155.1	ABT-263 (navitoclax)	Colon adenocarcinoma	0.002845958	Resistant
ENSG00000234155.1	ABT-263 (navitoclax)	Pancreatic adenocarcinoma	0.033058287	Sensitive